Table 1 Association between PLCD1 expression and clinicopathological parameters of KIRC patients in TCGA
Characteristic | Low expression of PLCD1 | High expression of PLCD1 | p value |
|---|---|---|---|
n | 269 | 270 | |
T stage, n (%) | < 0.001 | ||
T1 | 118 (21.9%) | 160 (29.7%) | |
T2 | 33 (6.1%) | 38 (7.1%) | |
T3 | 111 (20.6%) | 68 (12.6%) | |
T4 | 7 (1.3%) | 4 (0.7%) | |
N stage, n (%) | 0.593 | ||
N0 | 126 (49%) | 115 (44.7%) | |
N1 | 10 (3.9%) | 6 (2.3%) | |
M stage, n (%) | 0.001 | ||
M0 | 209 (41.3%) | 219 (43.3%) | |
M1 | 54 (10.7%) | 24 (4.7%) | |
Age, median (IQR) | 61 (53, 71) | 60 (51, 68.75) | 0.155 |